We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a notice concerning 25 batches of Irbesartan-containing products. The drug, typically used to treat high blood pressure, can also be used among some kidney patients. Health professionals have issued a notice to pharmacies and wholesalers so patients do not need to check their medications. Doctor Alison Cave, MHRA chief safety officer, said: “Patient safety is at the heart of what we do. We’re recalling batches of certain Irbesartan containing products as precautionary measures while we continue our investigation.”
Source: Read Full Article